Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -63.17 | 12.30 |
PEG Ratio (TTM) | -1.20 | 9.74 |
P/S Ratio (TTM) | 0.47 | 2.48 |
P/B Ratio (TTM) | 1.78 | 5.42 |
P/FCF Ratio (TTM) | -29.96 | 18.05 |
Price to 5YR AVG Earnings Ratio | -16.20 | 24.59 |
Price to 5YR AVG FCF Ratio | 13.52 | 20.16 |
Profitability (10%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.99% | 7.11% |
ROE (TTM) | -2.88% | 23.42% |
Net Profit Margin (TTM) | -0.74% | 10.52% |
ROIC 5YR AVG | 4.38% | -27.73% |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -599.98% | -542.90% | -384.62% |
Revenue | 1.90% | -1.91% | -0.32% |
Net Income | -600.13% | -549.61% | -389.80% |
Cash Flow | 176.49% | 6.30% | -3.46% |
Health (44%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.69 | 1.94 |
Quick Ratio (TTM) | 1.56 | 1.47 |
D/E Ratio (TTM) | 1.12 | 1.85 |
Interest Coverage (TTM) | 1.29 | 13.30 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 2.12 | 4.38 |
LTL to 5YR AVG FCF | 7.13 | 1.64 |
Shares Outstanding Growth 5YR AVG | 0.62% | 3.82% |